Curaleaf (Biotechnology) Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 5,650

Employees

  • Stock Symbol
  • CURA

Stock Symbol

  • Investments
  • 34

  • Share Price
  • $4.03
  • (As of Monday Closing)

Curaleaf (Biotechnology) General Information

Description

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.

Contact Information

Formerly Known As
PalliaTech, PalliaTech, Inc.
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
TSE
Corporate Office
  • 420 Lexington Avenue
  • Suite 2035
  • New York, NY 10170
  • United States
+1 (781) 000-0000

Curaleaf (Biotechnology) Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curaleaf (Biotechnology) Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.03 $4.00 $2.51 - $6.39 $2.99B 742M 451K -$0.38

Curaleaf (Biotechnology) Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 4,850,637 3,940,986 3,970,217 6,593,818
Revenue 1,355,953 1,346,632 1,275,420 1,195,987
EBITDA 187,969 187,907 167,859 149,249
Net Income (275,130) (281,197) (370,099) (205,940)
Total Assets 3,083,098 3,096,576 3,414,560 3,105,073
Total Debt 871,666 883,547 928,729 652,403
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Curaleaf (Biotechnology) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Curaleaf (Biotechnology)‘s full profile, request access.

Request a free trial

Curaleaf (Biotechnology) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in t
Biotechnology
New York, NY
5,650 As of 2023
00000
000000000 00000

000000

itation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
00000 00000000000000
Vancouver, Canada
0000 As of 0000
00000
000000000 00000

000000

trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
000000000 000000
Quincy, FL
0000 As of 0000
00000
00000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Curaleaf (Biotechnology) Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cresco Labs Formerly VC-backed Vancouver, Canada 0000 00000 000000000 00000
Trulieve Cannabis Corporate Backed or Acquired Quincy, FL 0000 00000 000000&0 00000
Verano Holdings Corporation Chicago, IL 0000 00000 0000 00000
Green Thumb Industries Corporation Chicago, IL 0000 00000 000000000 00000
Tilray Brands Formerly PE-Backed Leamington, Canada 0000 00000 000000000 00000
You’re viewing 5 of 9 competitors. Get the full list »

Curaleaf (Biotechnology) Patents

Curaleaf (Biotechnology) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11629986-B2 Squeeze doser with childproof cap Active 22-Jul-2021 0000000000 00
US-20230026087-A1 Squeeze doser with childproof cap Active 22-Jul-2021 0000000000 00
US-20230392966-A1 Squeeze doser with childproof cap Pending 22-Jul-2021 0000000000 0
CA-2804124-C Cannabis drug delivery and monitoring system Inactive 28-Jun-2010 00000000000
CA-2804124-A1 Cannabis drug delivery and monitoring system Active 28-Jun-2010 A61M15/0028
To view Curaleaf (Biotechnology)’s complete patent history, request access »

Curaleaf (Biotechnology) Executive Team (32)

Name Title Board Seat Contact Info
Matthew Darin Chief Executive Officer
Edward Kremer Chief Financial Officer
James Shorris JD Chief Compliance Officer, Legal
John Manzanares Chief Information Officer
Camilo Lyon Chief Investment Officer, Investments
You’re viewing 5 of 32 executive team members. Get the full list »

Curaleaf (Biotechnology) Board Members (8)

Name Representing Role Since
00000 000000 Self Chairman & Board Member 000 0000
000000000 000000 0 Self Board Member 000 0000
000000 0000000 Curaleaf (Biotechnology) Board Member & Vice Chairman 000 0000
0000 000000000 Curaleaf (Biotechnology) Board Member 000 0000
00000000 0000 00 Grassroots Cannabis Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Curaleaf (Biotechnology) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curaleaf (Biotechnology) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Curaleaf (Biotechnology)‘s full profile, request access.

Request a free trial

Curaleaf (Biotechnology) Investments & Acquisitions (34)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Northern Green Canada 22-Apr-2024 0000000000 Pharmaceuticals 00000 000
Dark Heart Nursery 17-Jan-2024 0000000000 Pharmaceuticals
Half Moon Nursery 17-Jan-2024 0000000000 00000 Cultivation
Clever Leaves (Cannabis Processing Facility in Setúbal, Portugal) 05-Jul-2023 000000000 Buildings and Property 0000000 0
Deseret Wellness 10-Apr-2023 Merger/Acquisition 0000 Other Pharmaceuticals and Biotechnology 0000000 0
You’re viewing 5 of 34 investments and acquisitions. Get the full list »

Curaleaf (Biotechnology) Subsidiaries (6)

Company Name Industry Location Founded
Alternative Therapies Group II Other Pharmaceuticals and Biotechnology Salem, MA 2015
Northern Green Canada Pharmaceuticals Brampton, Canada 0000
Grassroots Cannabis Other Consumer Non-Durables Chicago, IL 0000
The Spot 420 Other Pharmaceuticals and Biotechnology Pueblo, CO 0000
Dark Heart Nursery Pharmaceuticals San Leandro, CA 0000
You’re viewing 5 of 6 subsidiaries. Get the full list »

Curaleaf (Biotechnology) ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Curaleaf (Biotechnology)’s complete esg history, request access »

Curaleaf (Biotechnology) Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
Los Sueños Farms 04-Oct-2021 000000000000000000 0000 Completed
  • 00000000 (00000000
Elevate Takoma Dispensary 10-Jan-2019 Corporate Asset Purchase Completed
To view Curaleaf (Biotechnology)’s complete exits history, request access »

Curaleaf (Biotechnology) FAQs

  • When was Curaleaf (Biotechnology) founded?

    Curaleaf (Biotechnology) was founded in 2010.

  • Who is the CEO of Curaleaf (Biotechnology)?

    Matthew Darin is the CEO of Curaleaf (Biotechnology).

  • Where is Curaleaf (Biotechnology) headquartered?

    Curaleaf (Biotechnology) is headquartered in New York, NY.

  • What is the size of Curaleaf (Biotechnology)?

    Curaleaf (Biotechnology) has 5,650 total employees.

  • What industry is Curaleaf (Biotechnology) in?

    Curaleaf (Biotechnology)’s primary industry is Biotechnology.

  • Is Curaleaf (Biotechnology) a private or public company?

    Curaleaf (Biotechnology) is a Public company.

  • What is Curaleaf (Biotechnology)’s stock symbol?

    The ticker symbol for Curaleaf (Biotechnology) is CURA.

  • What is the current stock price of Curaleaf (Biotechnology)?

    As of 17-Jun-2024 the stock price of Curaleaf (Biotechnology) is $4.03.

  • What is the current market cap of Curaleaf (Biotechnology)?

    The current market capitalization of Curaleaf (Biotechnology) is $2.99B.

  • What is Curaleaf (Biotechnology)’s current revenue?

    The trailing twelve month revenue for Curaleaf (Biotechnology) is $1.36B.

  • Who are Curaleaf (Biotechnology)’s competitors?

    Cresco Labs, Trulieve Cannabis, Verano Holdings, Green Thumb Industries, and Tilray Brands are some of the 9 competitors of Curaleaf (Biotechnology).

  • What is Curaleaf (Biotechnology)’s annual earnings per share (EPS)?

    Curaleaf (Biotechnology)’s EPS for 12 months was -$0.38.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »